Cognios Beta Neutral Large Cap Fund, LP Incyte Corp Transaction History
Cognios Beta Neutral Large Cap Fund, LP
- $74.5 Million
- Q1 2024
A detailed history of Cognios Beta Neutral Large Cap Fund, LP transactions in Incyte Corp stock. As of the latest transaction made, Cognios Beta Neutral Large Cap Fund, LP holds 8,481 shares of INCY stock, worth $608,257. This represents 0.65% of its overall portfolio holdings.
Number of Shares
8,481
Previous 9,318
8.98%
Holding current value
$608,257
Previous $585,000
17.44%
% of portfolio
0.65%
Previous 0.79%
Shares
5 transactions
Others Institutions Holding INCY
# of Institutions
643Shares Held
186MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.2 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.53 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.46 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.1 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$757 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...